The latest news from Arcinova
Arcinova strengthens API servicesArcinova has made a major investment in its Active Pharmaceutical Ingredient (API) capabilities. We are pleased to announce that we have introduced two new 20-litre GMP vessel streams to o
EBF Workshop Presentation, LisbonStuart’s presentation, entitled General Principles of Stability Testing: What Is A Single Source? formed part of the EBF’s Industry input into ICH M10: Experimental data as the cornerstone for
Arcinova are now a member of Science ExchangeThe Science Exchange is an online collaboration platform designed to enable the outsourcing of research and development services. The Science Exchange is 'the leading marketplace for scientific re
Arcinova partakes in The Stephen Carey Fund defibrillator trainingThe Stephen Carey Fund work with communities and organisations throughout Northumberland to help combat cardiac arrest. The fund was launched in 2013 as attempt to introduce life-saving skills and
Arcinova Q2 Newsletter 2017The Q2 newsletter, reporting updates for each department and the installation of the Uniqsis continuous flow equipment as a means to enhance our capabilities.
Arcinova Invests in Uniqsis FlowSyn™ Continuous Flow ReactorThe addition of the Uniqsis FlowSyn™ reactor will enable Arcinova to develop and simplify the scale-up of a challenging API batch process.
Integrated Services: Covance and Arcinova strategic relationshipCovance and Arcinova recently expanded a strategic relationship following the signing of a sales services agreement at the end of 2016. Under the terms of the agreement, Covance is offering Arcino
Enterprise Hub founding Chair to receive President’s MedalA leading engineer with a passion for fostering innovation and entrepreneurship is to be recognised with one of the Royal Academy of Engineering’s most prestigious prizes. Ian Shott CBE
FW Capital: Arcinova set to grow with £750,000 investmentArcinova was established in September 2015 by highly experienced life science entrepreneurs Ian Shott and Paul Ryan. In February 2016, it acquired a modern 15,000 sq.m. pharmaceutical Resear
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.